The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Sitero is pleased to announce the addition of Jeff Huntsman to its growing leadership team as Chief Commercial Officer. Jeff brings over 30 years of ...
read more
Tuesday, January 31, 2023
Sandoz announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a positive opinion...
read more
Merck announced that the FDA approved KEYTRUDA, Merck’s anti-PD-1 therapy, as a single agent, for adjuvant treatment following surgical resection and ...
read more
The Alzheimer's Association appreciates the Food and Drug Administration's (FDA) methodical process in reviewing treatments for Alzheimer's disease.
read more
Dr. Reddy’s Laboratories Ltd. has successfully completed the full set of clinical studies of its proposed rituximab biosimilar candidate, DRL_RI, for ...
read more
Wednesday, January 18, 2023
Celltrion Healthcare Canada Limited announced that Health Canada granted a notice of compliance (NOC) on January 3, 2023 for Vegzelma®, a biosimilar ...
read more
Wednesday, January 18, 2023
Evaxion Biotech A/S announced that the FDA granted fast-track designation for the Company’s personalized cancer therapy, EVX-01, in combination with ...
read more
Tuesday, January 17, 2023
Alvotech and Fuji Pharma Co., Ltd. have decided to expand their existing exclusive commercialization partnership covering Japan, by adding a new ...
read more
Tuesday, January 17, 2023
CN Bio announced that the FDA and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ MPS ...
read more
Thursday, January 12, 2023
Mallinckrodt plc announced that Dr. Peter Richardson, B.Med.Sci., BM, BS, MRCP (UK) has been appointed Executive Vice President and Chief Scientific ...
read more
Tuesday, January 10, 2023
BioNTech SE and InstaDeep have entered into an agreement under which BioNTech will acquire InstaDeep, a leading global technology company in the field...
read more
Tuesday, January 10, 2023
Novavax, Inc. announced that John C. Jacobs will succeed Stanley C. Erck as President and Chief Executive Officer and a member of the Board of ...
read more
Santhera Pharmaceuticals and ReveraGen BioPharma, Inc. announced that the FDA accepted the new drug application (NDA) for vamorolone for the treatment...
read more
Amneal Pharmaceuticals, Inc. has signed a long-term license agreement with Orion Corporation to commercialize a number of Amneal’s complex generic ...
read more
Orchard Therapeutics announced the FDA cleared its Investigational New Drug (IND) application for OTL-203, a hematopoietic stem cell (HSC) gene ...
read more